Ledger.Open graph →
SEC Form D · filed April 7, 2023

GlycosBio Inc

Offering
$1.0M
Sold
$425K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Houston, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Joseph C. Walowski · Houston, TXDirectorFrank C. Foster · Santa Barbara, CADirectorVictoria C. Niklas · Houston, TXDirectorDan C. Watkins · Houston, TXDirectorRichard C. Cilento · Houston, TXExec · DirectorJohn Pollesel · Toronto, Ontario, CanadaDirectorDavid Stetson · Toronto, Ontario, CanadaDirectorSusan Uthayakumar · Toronto, Ontario, CanadaDirectorAndrew Lee · New York, NYDirectorGail J. Makode · Hunt Valley, MDDirectorNic Pannekeet · Seattle, WADirectorSusumu J. Kodera · Irvine, CADirectorWayne Byrne · Seattle, WADirectorRichard C. Cilento · Houston, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗